Selenium and Vitamin E for Prevention of Non–Muscle-Invasive Bladder Cancer Recurrence and Progression

安慰剂 医学 维生素E 维生素 内科学 随机化 胃肠病学 临床试验 外科 病理 生物 抗氧化剂 冶金 替代医学 材料科学 生物化学
作者
Richard T. Bryan,Sarah Pirrie,Ben Abbotts,Shanna Maycock,Vinnie During,Carolyn Lewis,Margaret Grant,Deborah Bird,Adam J. Devall,D. Michael A. Wallace,Nicholas D. James,Lucinda Billingham,Maurice P. Zeegers,Kar Keung Cheng,Gun Choudry,Sikander Khwaja,Ken Desai,Kieran Jefferson,L. A. EMTAGE,Aniruddha Chakravarti,Michael Foster,B Dev Sarmar,Christopher J. Luscombe,D. Michael A. Wallace,Nicholas James,Peter Cooke,Krzysztof Kadow,John Parkin,Adel Makar
出处
期刊:JAMA network open [American Medical Association]
卷期号:6 (10): e2337494-e2337494 被引量:8
标识
DOI:10.1001/jamanetworkopen.2023.37494
摘要

Selenium and vitamin E have been identified as promising agents for the chemoprevention of recurrence and progression of non-muscle-invasive bladder cancer.To determine whether selenium and/or vitamin E may prevent disease recurrence in patients with newly diagnosed NMIBC.This multicenter, prospective, double-blinded, placebo-controlled, 2 × 2 factorial randomized clinical trial included patients with newly diagnosed NMIBC recruited from 10 secondary or tertiary care hospitals in the UK. A total of 755 patients were screened for inclusion; 484 did not meet the inclusion criteria, and 1 declined to participate. A total of 270 patients were randomly assigned to 4 groups (selenium plus placebo, vitamin E plus placebo, selenium plus vitamin E, and placebo plus placebo) in a double-blind fashion between July 17, 2007, and October 10, 2011. Eligibility included initial diagnosis of NMIBC (stages Ta, T1, or Tis); randomization within 12 months of first transurethral resection was required.Oral selenium (200 μg/d of high-selenium yeast) and matched vitamin E placebo, vitamin E (200 IU/d of d-alfa-tocopherol) and matched selenium placebo, selenium and vitamin E, or placebo and placebo.Recurrence-free interval (RFI) on an intention-to-treat basis (analyses completed on November 28, 2022).The study randomized 270 patients (mean [SD] age, 68.9 [10.4] years; median [IQR] age, 69 [63-77] years; 202 male [75%]), with 65 receiving selenium and vitamin E placebo, 71 receiving vitamin E and selenium placebo, 69 receiving selenium and vitamin E, and 65 receiving both placebos. Median overall follow-up was 5.5 years (IQR, 5.1-6.1 years); 228 patients (84%) were followed up for more than 5 years. Median treatment duration was 1.5 years (IQR, 0.9-2.5 years). The study was halted because of slow accrual. For selenium (n = 134) vs no selenium (n = 136), there was no difference in RFI (hazard ratio, 0.92; 95% CI, 0.65-1.31; P = .65). For vitamin E (n = 140) vs no vitamin E (n = 130), there was a statistically significant detriment to RFI (hazard ratio, 1.46; 95% CI, 1.02-2.09; P = .04). No significant differences were observed for progression-free interval or overall survival time with either supplement. Results were unchanged after Cox proportional hazards regression modeling to adjust for known prognostic factors. In total, 1957 adverse events were reported; 85 were serious adverse events, and all were considered unrelated to trial treatment.In this randomized clinical trial of selenium and vitamin E, selenium supplementation did not reduce the risk of recurrence in patients with NMIBC, but vitamin E supplementation was associated with an increased risk of recurrence. Neither selenium nor vitamin E influenced progression or overall survival. Vitamin E supplementation may be harmful to patients with NMIBC, and elucidation of the underlying biology is required.isrctn.org Identifier: ISRCTN13889738.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ohh完成签到,获得积分10
2秒前
2秒前
英俊的铭应助快乐源泉采纳,获得10
3秒前
羊羊羊完成签到,获得积分10
3秒前
嘒彼小星完成签到 ,获得积分10
4秒前
小洪俊熙完成签到,获得积分10
5秒前
Hello应助stronger采纳,获得10
5秒前
5秒前
Ellie完成签到 ,获得积分10
6秒前
7秒前
7秒前
田様应助郭小宝采纳,获得10
7秒前
8秒前
所所应助aka鱼鱼鱼采纳,获得10
8秒前
10秒前
10秒前
xiaohu6311发布了新的文献求助10
11秒前
Jasper应助古夕采纳,获得10
11秒前
xiaowang发布了新的文献求助10
11秒前
张二狗发布了新的文献求助30
11秒前
瑶啊瑶完成签到,获得积分10
12秒前
daimin发布了新的文献求助10
13秒前
13秒前
sundial发布了新的文献求助10
13秒前
zzh完成签到 ,获得积分10
13秒前
成就的翠琴完成签到,获得积分10
14秒前
15秒前
科研通AI2S应助任性蘑菇采纳,获得10
15秒前
单纯的丹萱完成签到,获得积分10
15秒前
16秒前
heyihao完成签到,获得积分10
16秒前
16秒前
科研通AI2S应助xiaowang采纳,获得10
17秒前
日常常完成签到,获得积分10
18秒前
18秒前
yar给chen的求助进行了留言
19秒前
故晨发布了新的文献求助10
19秒前
19秒前
20秒前
万能图书馆应助Sir.夏季风采纳,获得10
20秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Economic Geography and Public Policy 900
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988786
求助须知:如何正确求助?哪些是违规求助? 3531116
关于积分的说明 11252493
捐赠科研通 3269766
什么是DOI,文献DOI怎么找? 1804771
邀请新用户注册赠送积分活动 881870
科研通“疑难数据库(出版商)”最低求助积分说明 809021